Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid

• click to rate

  Posted by Two Blokes Jun 20 - Filed in Stock - 7 views
  
  SNY and REGN's Dupixent gets FDA approval for a rare and chronic skin disease, marking its eighth approved indication for the drug.